Abstract:Gliomas, a type of primary brain tumor, have emerged as a threat to global mortality due to their high heterogeneity and mortality. A low-grade glioma (LGG), although less aggressive compared with glioblastoma, still exhibits high recurrence and malignant progression. Ubiquitination is one of the most important posttranslational modifications that contribute to carcinogenesis and cancer recurrence. E3-related genes (E3RGs) play essential roles in the process of ubiquitination. Yet, the biological function and clinical significance of E3RGs in LGGs need further exploration. In this study, differentially expressed genes (DEGs) were screened by three differential expression analyses of LGG samples from The Cancer Genome Atlas (TCGA) database. DEGs with prognostic significance were selected by the univariate Cox regression analysis and log-rank statistical test. The LASSO-COX method was performed to identify an E3-related prognostic signature consisting of seven genes AURKA, PCGF2, MAP3K1, TRIM34, PRKN, TLE3, and TRIM17. The Chinese Glioma Genome Atlas (CGGA) dataset was used as the validation cohort. Kaplan-Meier survival analysis showed that LGG patients in the low-risk group had significantly higher overall survival time than those in the high-risk group in both TCGA and CGGA cohorts. Furthermore, multivariate Cox regression analysis revealed that the E3RG signature could be used as an independent prognostic factor. A nomogram based on the E3RG signature was then established and provided the prediction of the 1-, 3-, and 5-year survival probability of patients with LGGs. Moreover, DEGs were analyzed based on the risk signature, on which function analyses were performed. GO and KEGG analyses uncovered gene enrichment in extracellular matrix-related functions and immune-related biological processes in the high-risk group. GSEA revealed high enrichment in pathways that promote tumorigenesis and progression in the high-risk group. Furthermore, ESTIMATE algorithm analysis showed a significant difference in immune and stroma activity between high- and low-risk groups. Positive correlations between the risk signature and the tumor microenvironment immune cell infiltration and immune checkpoint molecules were also observed, implying that patients with the high-risk score may have better responses to immunotherapy. Overall, our findings might provide potential diagnostic and prognostic markers for LGG patients and offer meaningful insight for individualized treatment.

ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma

Glioma Angiogenesis is Boosted by ELK3 Activating the HIF-1 Α /VEGF-A Signaling Axis

PBX3 as a biomarker for the early diagnosis and prediction of prognosis of glioma

Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.

Comprehensive Characterization of a Novel E3-Related Gene Signature with Implications in Prognosis and Immunotherapy of Low-Grade Gliomas.

Prognostic Implications of Epidermal Growth Factor Receptor Variant III Expression and Nuclear Translocation in Chinese Human Gliomas

Diagnostic and Prognostic Potentials of Long Noncoding RNA ELF3-AS1 in Glioma Patients

CSF3R as a potential prognostic biomarker and immunotherapy target in glioma

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

New prognostic biomarker CMTM3 in low grade glioma and its immune infiltration

B-cell CLL/lymphoma 3 gene expression: a new prognostic factor for glioma

MLK3 Is Associated With Poor Prognosis in Patients With Glioblastomas and Actin Cytoskeleton Remodeling in Glioblastoma Cells

CHI3L1 As a Prognostic Biomarker and Therapeutic Target in Glioma

The Potential Significance of the EMILIN3 Gene in Augmenting the Aggressiveness of Low-Grade Gliomas is Noteworthy

ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma

Epithelial Membrane Protein-3 and Chitinase-3-like Protein-1 As New Prognostic Predictors of Glioma, a Two-Gene Study

TRAF3IP3 promotes glioma progression through the ERK signaling pathway

Identification and Validation of a Three-Gene Signature As a Candidate Prognostic Biomarker for Lower Grade Glioma

Clinical Significance of Angiopoietin-Like Protein 3 Expression in Patients with Glioblastoma

GSK-3 beta regulates tumor growth and angiogenesis in human glioma cells

Genomic profiling identified novel prognostic biomarker in Chinsese glioma patients.